News Headlines Article

Consumers Rejected Drug Plan That Mirrors Trump Administration Proposal
Kaiser Health News

Unraveling how much of a prescription drug price gets swallowed by “middlemen” is at the forefront of Tuesday’s drug price hearing in the Senate. One thing bound to come up: rebates.

Both major political parties have shown interest in remedying high drug prices, and drugmakers have bemoaned how rebates to middlemen keep them from reaping every dollar associated with those price tags.

Pharmacy giant CVS Health criticized the Trump administration’s proposal to end these post-transaction discounts as they apply to Medicare.  Yet, in January the company rolled out a Medicare drug plan that experts say is similar “in spirit” to the administration’s proposal.